LAD vs NBIX · P/E 10, rev $19.06B vs P/E 45, rev $1.77B
Lithia Motors Inc (LAD) versus Neurocrine Biosciences Inc (NBIX) — a side-by-side from cached financials, not a winner call.
Lithia Motors Inc (LAD) is a auto & truck dealerships company listed on NYSE.
Neurocrine Biosciences Inc (NBIX) is a drug manufacturers - specialty & generic company listed on US.
Latest reported LAD revenue for 2026-06-30 was $19.06B. Net income was $360.4M. LAD currently screens at market cap $6.68B and trailing P/E 10.2.
Latest reported NBIX revenue for 2026-06-30 was $1.77B. Net income was $342.3M. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
LAD currently screens at market cap $6.68B and trailing P/E 10.2. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
Not investment advice. Open the LAD and NBIX stock pages for the full models.
Not investment advice.